MHMartina Hautmann

Martina Hautmann

*This is an algorithmically generated author record based on publicly available information.

Martina Hautmann has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Non-Invasive Measurement of Hemodynamic Parameters via Whole-Body Impedance Cardiography Among Hospitalized Heart Failure Patients: An Effective Alternative to Invasive Right Heart Catheterization?

    by Felix Ausbuettel, Sabah Khwamurad, Murad Haj Abdo, Sebastian Kerber, Karin Nentwich, Martina Hautmann, Sebastian Barth

    (1) Background: The measurement of hemodynamic parameters has proven to be crucial in the treatment of hospitalized heart failure patients, necessitating invasive measurement by right heart catheterization (RHC). The reliability of whole-body impedance cardiography (ICG) among this cohort has not been investigated to date; (2) Methods: The RHC and whole-body ICG examinations measured cardiac output (CO), the cardiac index (CI), total peripheral resistance (TPR), and pulmonary vascular resistance (PVR). To assess the accuracy of the whole-body ICG measurement, bias and precision were calculated as the mean difference and the twofold standard deviation between the average values of measurements; (3) Results: A total of 203 patients were analyzed. No significant bias was observed between the non-invasive CO and CI measurements when compared with the RHC measurements (−0.14 ± 2.56 L/min, p = 0.1; −0.09 ± 1.3 L/min/m2, p = 0.06), but a significant bias occurred in the measurement of non-invasive TPR and non-invasive PVR (−1243 ± 3510 dyn × s−1 × cm−5, p = 0.001; −121 ± 504 dyn × s−1 × cm−5, p < 0.001); (4) Conclusions: CO and CI can be measured with whole-body ICG among hospitalized CHF patients with acceptable accuracy. The reliability of measuring TPR and PVR should be further investigated.

  • Open Access

    A Cross-Sectoral Telemedicine Network (sekTOR-HF) for Patients with Heart Failure

    by Sebastian Barth, Martina Hautmann, Wilko Reents, Goran Trajkovski, Brigitte Gebhard, Sebastian Kerber, Michael Zacher, Dimitar Divchev, Bernhard Schieffer

    Objectives: Heart failure is associated with frequent hospital admissions and high mortality. Digital medical technologies could help to improve information exchange between healthcare providers and patients to prevent recurrent cardiac decompensation. Methods: Eligible patients aged between 18 and 85 (mean age 65 ± 12; 35.4% female) with symptomatic heart failure were included in this cross-sectoral telemedicine network (sekTOR-HF) study (n = 79) with a 12-month intervention period. Depending on the severity of heart failure at the time of inclusion, patients in the intervention group were labeled either as inpatients (NYHA III–IV) or outpatients (NYHA I–II). All patients not included served as the control group. Nearest Neighbor Propensity Score Matching was performed to obtain a control group of the same size. Patients in the intervention group received an electronic patient record with all relevant health data in an eHealth portal and the option to use learning modules. A coordinating network office supported all patients in the intervention group. Monitoring included patient self-measurement of blood pressure, weight, heart rate, and oxygen saturation and a digital electrocardiogram. The primary endpoint was all-cause rehospitalization in both groups. Results: The cumulative incidence for all-cause rehospitalization was lower in the intervention group compared to the control group (sHR 1.86; 95% CI: 1.12–3.09). There was no difference in all-cause mortality (HR 1.5; 95% CI: 0.53–4.21). Conclusions: Intervention management in this cross-sectoral telemedicine network led to a lower cumulative incidence of all-cause rehospitalization even in the early phase of intervention.


  • Open Access

    Left atrial appendage thrombus formation, potential of resolution and association with prognosis in a large real-world cohort

    by Martina Hautmann, Michael Zacher, Sophia Fuchs, Christian Muñoz Pérez, Akram Ahmidou, Sebastian Kerber, Sebastian Barth

    Comprehensive data on factors influencing left atrial appendage (LAA) thrombus formation, resolution and impact on survival are limited. In this single-center, retrospective study 7759 (2010–2015) patients with symptomatic ongoing atrial fibrillation (AF) on admission were screened for LAA thrombi. 450 patients had LAA thrombi. 481 patients without LAA thrombi were randomly selected as controls. We assessed clinical, echocardiographic, laboratory parameters and long-term survival of both groups. Patients with LAA thrombi compared to controls were older, had more strokes, higher CHA2DS2 -VASc scores, worse renal function, less controlled diabetes, advanced heart failure, lower LAA emptying velocities, higher levels of cardiac and inflammatory markers (all p < 0.001). 56.3% of followed-up patients (304) dissolved their LAA thrombi. Chances of thrombus resolution increased with rising LAA flow velocities (OR 1.061, p = 0.022), whereas advanced age (OR 0.950, p < 0.001) and presence of permanent AF (OR 0.354, p < 0.001) decreased chances of thrombus resolution. Presence of LAA thrombi was associated with a markedly reduced 10-year survival probability (31% versus 69%). LAA thrombus formation is promoted by advanced structural heart disease, inflammation, diabetes and impaired renal function. Younger age, non-permanent AF and higher LAA flow velocities were predictors of thrombus resolution. Thrombus formation was associated with poor prognosis.


  • Functional and hemodynamic results after transcatheter mitral valve leaflet repair with the PASCAL device depending on etiology in a real-world cohort

    by Sebastian Barth, Alaa Shalla, Jan Kikec, Sebastian Kerber, Michael Zacher, Wilko Reents, Lukas Lehmkuhl, Borek Foldyna, Philipp Halbfass, Ulrich Lüsebrink, et al.


  • Mid-term hemodynamic and functional results after transcatheter mitral valve leaflet repair with the new PASCAL device

    by Sebastian Barth, Martina B. Hautmann, Eleni Arvaniti, Jan Kikec, Sebastian Kerber, Michael Zacher, Philipp Halbfass, Patrick Ranosch, Lukas Lehmkuhl, Borek Foldyna, et al.

    Aims To examine the functional and hemodynamic mid-term outcome at 5 months of mitral regurgitation (MR) reduction using the PASCAL repair system. Methods and results Between July 2019 and February 2020 31 consecutive patients with MR 3 +/4 + (mean age 77.5 years, all in New York Heart Association (NYHA) class III–IV, STS score 9.1 ± 7.4) underwent MR reduction in our institute using the PASCAL device. 61.3% had a functional, 29.0% a degenerative, and 9.7% a mixed etiology. Successful implantation was achieved in 30/31 (96.8%) patients. 27/31 patients (87.1%) completed 5-month follow-up with clinical, echocardiographic, laboratory and hemodynamic assessment. At 5 months, 70.4% of the patients had MR grade ≤ 1 (p < 0.001). 85.2% were in NYHA class I or II (p < 0.001). Six-minute walk distance improved by 145 m (p = 0.010), Kansas City cardiomyopathy questionnaire and European quality of life 5 dimensions questionnaire (EQ5D) improved by 31 (p < 0.001) and 9 points (p = 0.001), respectively. Mean pulmonary capillary wedge pressure decreased significantly from 22.1 ± 9 mmHg to 17.3 ± 8 mmHg (p = 0.041) and right atrial pressure from 10.3 ± 6 mmHg to 8.0 ± 6 mmHg (p = 0.013) from baseline to 5 months. In addition, propensity score matching showed that PASCAL and MitraClip procedures resulted in equally hemodynamic and functional improvement. Conclusion MR reduction of severe MR with the PASCAL device is feasible and safe regardless of etiologies. Mid-term follow-up at 5 months showed a sustained MR reduction, improvement of exercise capacity, quality of life, proBNP levels and hemodynamics regarding pulmonary capillary wedge pressure and right atrial pressure. Graphic abstract